Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

被引:41
作者
Wang, Jing [1 ]
Xue, Yunfan [1 ]
Liu, Jun [1 ]
Hu, Mi [1 ]
Zhang, He [1 ]
Ren, Kefeng [1 ]
Wang, Yunbing [2 ]
Ji, Jian [1 ]
机构
[1] Zhejiang Univ, MOE Key Lab Macromol Synth & Functionalizat, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China
[2] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China
基金
中国国家自然科学基金;
关键词
SURFACE-MEDIATED TRANSFECTION; CARDIOVASCULAR STENT; NITRIC-OXIDE; GROWTH; THROMBOSIS; RELEASE; RESTENOSIS; HEPARIN; PHOSPHORYLATION; MECHANISMS;
D O I
10.34133/2020/1458090
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The drug-eluting stent (DES) has become one of the most successful and important medical devices for coronary heart disease, but yet suffers from insufficient endothelial cell (EC) growth and intima repair, eventually leading to treatment failure. Although biomacromolecules such as vascular endothelial growth factor (VEGF) would be promising to promote the intima regeneration, combining hydrophilic and vulnerable biomacromolecules with hydrophobic drugs as well as preserving the bioactivity after harsh treatments pose a huge challenge. Here, we report on a design of hierarchical capillary coating, which composes a base solid region and a top microporous region for incorporating rapamycin and VEGF, respectively. The top spongy region can guarantee the efficient, safe, and controllable loading of VEGF up to 1 mu g/cm(2) in 1 minute, providing a distinctive real-time loading capacity for saving the bioactivity. Based on this, we demonstrate that our rapamycin-VEGF hierarchical coating impressively promoted the competitive growth of endothelial cells over smooth muscle cells (ratio of EC/SMC similar to 25) while relieving the adverse impact of rapamycin to ECs. We further conducted the real-time loading of VEGF on stents and demonstrate that the hierarchical combination of rapamycin and VEGF showed remarkable endothelium regeneration while maintaining a very low level of in-stent restenosis. This work paves an avenue for the combination of both hydrophobic and hydrophilic functional molecules, which should benefit the next generation of DES and may extend applications to diversified combination medical devices.
引用
收藏
页数:14
相关论文
共 62 条
[1]  
Abdoul-Carime H, 2002, RADIAT RES, V158, P23, DOI 10.1667/0033-7587(2002)158[0023:AOPSIB]2.0.CO
[2]  
2
[3]   Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort) [J].
Adriaenssens, Tom ;
Joner, Michael ;
Godschalk, Thea C. ;
Malik, Nikesh ;
Alfonso, Fernando ;
Xhepa, Erion ;
De Cock, Dries ;
Komukai, Kenichi ;
Tada, Tomohisa ;
Cuesta, Javier ;
Sirbu, Vasile ;
Feldman, Laurent J. ;
Neumann, Franz-Josef ;
Goodall, Alison H. ;
Heestermans, Ton ;
Buysschaert, Ian ;
Hlinomaz, Ota ;
Belmans, Ann ;
Desmet, Walter ;
ten Berg, Jurrien M. ;
Gershlick, Anthony H. ;
Massberg, Steffen ;
Kastrati, Adnan ;
Guagliumi, Giulio ;
Byrne, Robert A. .
CIRCULATION, 2017, 136 (11) :1007-+
[4]   In-Stent Atherosclerosis at a Crossroads Neoatherosclerosis ... or Paleoatherosclerosis? [J].
Andreou, Ioannis ;
Stone, Peter H. .
CIRCULATION, 2016, 134 (19) :1413-1415
[5]   Endothelial progenitor cell capture by stents coated with antibody against CD34 - The HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry [J].
Aoki, J ;
Serruys, PW ;
van Beusekom, H ;
Ong, ATL ;
McFadden, EP ;
Sianos, G ;
van der Giessen, WJ ;
Regar, E ;
de Feyter, PJ ;
Davis, HR ;
Rowland, S ;
Kutryk, MJB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1574-1579
[6]   Switching of cell growth/detachment on heparin-functionalized thermoresponsive surface for rapid cell sheet fabrication and manipulation [J].
Arisaka, Yoshinori ;
Kobayashi, Jun ;
Yamato, Masayuki ;
Akiyama, Yoshikatsu ;
Okano, Teruo .
BIOMATERIALS, 2013, 34 (17) :4214-4222
[7]   Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells -: Comparison of the effects of heparin and modified heparins [J].
Ashikari- Hada, S ;
Habuchi, H ;
Kariya, Y ;
Kimata, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (36) :31508-31515
[8]   Constitutive Endocytosis of VEGFR2 Protects the Receptor against Shedding [J].
Basagiannis, Dimitris ;
Christoforidis, Savvas .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (32) :16892-16903
[9]   Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease [J].
Bonaa, K. H. ;
Mannsverk, J. ;
Wiseth, R. ;
Aaberge, L. ;
Myreng, Y. ;
Nygard, O. ;
Nilsen, D. W. ;
Klow, N. -E. ;
Uchto, M. ;
Trovik, T. ;
Bendz, B. ;
Stavnes, S. ;
Bjornerheim, R. ;
Larsen, A. -I. ;
Slette, M. ;
Steigen, T. ;
Jakobsen, O. J. ;
Bleie, O. ;
Fossum, E. ;
Hanssen, T. A. ;
Dahl-Eriksen, O. ;
Njolstad, I. ;
Rasmussen, K. ;
Wilsgaard, T. ;
Nordrehaug, J. E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (13) :1242-1252
[10]  
Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391